11-47441836-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_005055.5(RAPSN):​c.776G>A​(p.Arg259His) variant causes a missense change. The variant allele was found at a frequency of 0.000158 in 1,584,224 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R259C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 2 hom. )

Consequence

RAPSN
NM_005055.5 missense

Scores

1
9
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 4.72

Publications

1 publications found
Variant links:
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
RAPSN Gene-Disease associations (from GenCC):
  • fetal akinesia deformation sequence 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • congenital myasthenic syndrome 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026453465).
BP6
Variant 11-47441836-C-T is Benign according to our data. Variant chr11-47441836-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476125.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAPSNNM_005055.5 linkc.776G>A p.Arg259His missense_variant Exon 4 of 8 ENST00000298854.7 NP_005046.2 Q13702-1A0A0S2Z4F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAPSNENST00000298854.7 linkc.776G>A p.Arg259His missense_variant Exon 4 of 8 1 NM_005055.5 ENSP00000298854.2 Q13702-1

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
151962
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000254
AC:
52
AN:
204462
AF XY:
0.000196
show subpopulations
Gnomad AFR exome
AF:
0.0000818
Gnomad AMR exome
AF:
0.000262
Gnomad ASJ exome
AF:
0.00265
Gnomad EAS exome
AF:
0.000124
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000163
Gnomad OTH exome
AF:
0.000383
GnomAD4 exome
AF:
0.000150
AC:
215
AN:
1432144
Hom.:
2
Cov.:
77
AF XY:
0.000148
AC XY:
105
AN XY:
710346
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33252
American (AMR)
AF:
0.000242
AC:
10
AN:
41354
Ashkenazi Jewish (ASJ)
AF:
0.00415
AC:
106
AN:
25568
East Asian (EAS)
AF:
0.000103
AC:
4
AN:
38938
South Asian (SAS)
AF:
0.0000364
AC:
3
AN:
82474
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44104
Middle Eastern (MID)
AF:
0.000481
AC:
2
AN:
4156
European-Non Finnish (NFE)
AF:
0.0000535
AC:
59
AN:
1102898
Other (OTH)
AF:
0.000455
AC:
27
AN:
59400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152080
Hom.:
0
Cov.:
31
AF XY:
0.000148
AC XY:
11
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0000964
AC:
4
AN:
41480
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67950
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000408
Hom.:
1
Bravo
AF:
0.000238
ExAC
AF:
0.000158
AC:
19

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Dec 16, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -

Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome Benign:1
Apr 13, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.048
T
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.65
D;.;.;.
Eigen
Benign
0.0088
Eigen_PC
Benign
0.18
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D;D;D;D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.026
T;T;T;T
MetaSVM
Uncertain
0.21
D
MutationAssessor
Benign
1.4
L;L;.;.
PhyloP100
4.7
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-2.7
D;N;N;D
REVEL
Uncertain
0.47
Sift
Benign
0.075
T;T;T;D
Sift4G
Uncertain
0.058
T;T;T;T
Polyphen
0.30
B;B;.;B
Vest4
0.46
MVP
0.92
MPC
0.30
ClinPred
0.064
T
GERP RS
5.2
Varity_R
0.23
gMVP
0.52
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766051613; hg19: chr11-47463388; API